Condition: Severe Alcohol Use Disorder (DSM 5) · Sponsor: Assistance Publique - Hôpitaux de Paris
Randomized clinical trial of 11 days Cannabidiol versus placebo as an adjunctive treatment during inpatient alcohol detoxification to improve abstinence in patients with severe alcohol use disorder.
This description comes directly from the study's public registry record.
Florence VORSPAN · 01 40 05 44 17 · Florence.vorspan@aphp.fr
Always discuss trial participation with your own doctor first.
| Hôpital Albert Chenevier | Créteil, Albert Chenevier, France | Recruiting |
| Hôpital Antoine Béclère | Clamart, Clamart, France | Not Yet Recruiting |
| CHU Gabriel Montpied | Clermont-Ferrand, Clermont Ferrand, France | Recruiting |
| Hôpital Louis Mourier | Colombes, Colombes, France | Withdrawn |
| Hôpital Avicenne | Bobigny, France, France | Not Yet Recruiting |
| Hôpital Fernand Widal | Paris, France, France | Recruiting |
| Hôpital Hôtel-Dieu | Paris, Paris, France | Not Yet Recruiting |
| Hôpital Cochin | Paris, Paris, France | Not Yet Recruiting |
| Hôpital Saint Anne | Paris, Paris, France | Recruiting |
| Hôpital Bichat | Paris, Paris, France | Withdrawn |
| Hôpital René Muret | Sevran, Sevran, France | Recruiting |
| Hôpital la Colombière | Montpellier, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05860699